PC
DPLO

PointState Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

PointState Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-67,900
Closed -$914K – 159
2018
Q4 		$914K Sell
67,900
-7,000
-9% -$118K 0.04% 78
2018
Q3 		$1.45M Buy
+74,900
New +$1.59M 0.02% 121

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PointState Capital's DPLO Position: Q1 2019 in Review

PointState Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 67,900 shares — an estimated $914K sold.

PointState Capital first reported a position in DPLO in Q3 2018 and held it in 2 quarters. The position peaked at $1.45M in Q3 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • PointState Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • PointState Capital sold 67,900 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $914K.
  • PointState Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2018 and held it in 2 quarters.
  • PointState Capital's DIPLOMAT PHARMACY, INC. position peaked at $1.45M in Q3 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on PointState Capital's 13F filing for Q1 2019, filed 15 May 2019.